Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office

Corporate Breaking News

Home : Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office

May 24 2021	Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office
LAUSANNE, Switzerland, May 24, 2021 /PRNewswire/ -- Gnubiotics Sciences SA (Gnubiotics), a Swiss biotech company pioneering novel microbiome targeted solutions for humans and companion animals, today announced the allowance from the European Patent Office (EPO) for its patent application...


Source:https://www.prnewswire.com:443/news-releases/gnubiotics-gains-allowance-of-patent-of-microbiome-markers-for-prediction-identification-and-treatment-of-pet-obesity-from-the-european-patent-office-301297533.html

Related News
» Global Automotive Image Sensors Market \| Europe to occupy 30% market share, faster growth expected in APAC \| Technavio » La Monnaie royale canadienne annonce ses bénéfices et ses résultats pour le premier trimestre 2021